James Feuille - Jun 11, 2025 Form 3 Insider Report for Chime Financial, Inc. (CHYM)

Role
Director
Signature
/s/ Theresa Bloom, by power of attorney
Stock symbol
CHYM
Transactions as of
Jun 11, 2025
Transactions value $
$0
Form type
3
Date filed
6/11/2025, 09:01 PM
Next filing
Jun 13, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Feuille James Director C/O CHIME FINANCIAL, INC., 101 CALIFORNIA STREET, SUITE 500, SAN FRANCISCO /s/ Theresa Bloom, by power of attorney 2025-06-11 0001318214

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CHYM Series A Preferred Stock Jun 11, 2025 Common Stock 16.2M See footnote F1, F2, F3
holding CHYM Series A-2 Preferred Stock Jun 11, 2025 Common Stock 5.07M See footnote F3, F4, F5
holding CHYM Series B Preferred Stock Jun 11, 2025 Common Stock 2.39M See footnote F3, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock will automatically convert into Common Stock on a 1.0089020772-for-1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock (the "IPO") and has no expiration date.
F2 These shares are held as follows: (i) 6,555,280 shares by Crosslink Crossover Fund VI, L.P. ("CO VI"); (ii) 6,263,780 shares by Crosslink Ventures VII, L.P. ("CV VII"); (iii) 2,684,056 shares by Crosslink Ventures VII-B, L.P. ("CV VII-B"); and (iv) 663,590 shares by Crosslink Bayview VII, LLC ("CB VII").
F3 The Reporting Person is: (i) a managing member of Crosslink Ventures VII Holdings, LLC, which is the general partner of CV VII and CV VII-B and the manager of CB VII; and (ii) a fund manager for Crossover Fund VI Management, L.L.C., the general partner of CO VI. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.
F4 Each share of Series A-2 Preferred Stock shall automatically convert into Common Stock on a 1:1 basis immediately prior to the completion of the IPO and has no expiration date.
F5 These shares are held as follows: (i) 2,908,030 shares by CV VII; (ii) 1,246,100 shares by CV VII-B; (iii) 607,470 shares by CO VI; and (iv) 308,080 shares by CB VII.
F6 Each share of Series B Preferred Stock shall automatically convert into Common Stock on a 1:1 basis immediately prior to the completion of the IPO and has no expiration date.
F7 These shares are held as follows: (i) 1,554,930 shares by CV VII; (ii) 666,290 shares by CV VII-B; and (iii) 164,730 shares by CB VII.

Remarks:

Exhibit 24 - Power of Attorney